These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 27394428)

  • 61. Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial.
    Iseri K; Watanabe M; Yoshikawa H; Mitsui H; Endo T; Yamamoto Y; Iyoda M; Ryu K; Inaba T; Shibata T
    J Bone Miner Res; 2019 Jun; 34(6):1014-1024. PubMed ID: 30690785
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hypercalcemia after discontinuation of long-term denosumab treatment.
    Koldkjær Sølling AS; Harsløf T; Kaal A; Rejnmark L; Langdahl B
    Osteoporos Int; 2016 Jul; 27(7):2383-2386. PubMed ID: 27098536
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
    Leder BZ; Tsai JN; Uihlein AV; Wallace PM; Lee H; Neer RM; Burnett-Bowie SA
    Lancet; 2015 Sep; 386(9999):1147-55. PubMed ID: 26144908
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sustained hypophosphatemia after denosumab in a patient on hemodialysis.
    Almodares AAS; Elder GJ; Abrahamsen B
    Bone; 2024 Apr; 181():117045. PubMed ID: 38341165
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of the efficacy of denosumab and bisphosphonates for treating secondary osteoporosis in patients with rheumatoid arthritis.
    Kinoshita H; Miyakoshi N; Kashiwagura T; Kasukawa Y; Sugimura Y; Shimada Y
    Mod Rheumatol; 2017 Jul; 27(4):582-586. PubMed ID: 27659808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.
    Langdahl BL; Teglbjærg CS; Ho PR; Chapurlat R; Czerwinski E; Kendler DL; Reginster JY; Kivitz A; Lewiecki EM; Miller PD; Bolognese MA; McClung MR; Bone HG; Ljunggren Ö; Abrahamsen B; Gruntmanis U; Yang YC; Wagman RB; Mirza F; Siddhanti S; Orwoll E
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1335-42. PubMed ID: 25607608
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients.
    Cianciolo G; Tondolo F; Barbuto S; Iacovella F; Zavatta G; Altieri P; Grandinetti V; Comai G; Cozzolino M; La Manna G
    Am J Nephrol; 2021; 52(8):611-619. PubMed ID: 34518468
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Osteoporosis Drug Increases Hypocalcemia Risk in Dialysis Patients.
    Aschenbrenner DS
    Am J Nurs; 2023 Mar; 123(3):20. PubMed ID: 36815815
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lower response to denosumab in diabetes patients on hemodialysis.
    Han SH; Jo HA; Han KH; Han SY
    Clin Nephrol; 2022 Feb; 97(2):70-77. PubMed ID: 34448695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients.
    Schoenmakers I; Fraser WD
    JAMA; 2024 Jun; 331(21):1864-1865. PubMed ID: 38717748
    [No Abstract]   [Full Text] [Related]  

  • 71. Severe hypocalcemia after denosumab administration in a patient with chronic kidney disease: a case report.
    Kouroglou E; Tsiama V; Dionysopoulou S; Gavriiloglou G; Bora M; Belis K; Proikaki S; Savvidis C; Giannou P; Petras D
    J Musculoskelet Neuronal Interact; 2023 Jun; 23(2):285-289. PubMed ID: 37259667
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Hypocalcemia Induced by Denosumab in Patients with Renal Insufficiency].
    Ishida K; Shimizu R; Endo I; Miyamoto S; Kawakami K
    Gan To Kagaku Ryoho; 2016 Jul; 43(7):875-8. PubMed ID: 27431632
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy and safety of denosumab treatment for Korean patients with Stage 3b-4 chronic kidney disease and osteoporosis.
    Kim JT; Kim YM; Jung KY; Choi H; Lee SY; Kim HJ
    Korean J Intern Med; 2024 Jan; 39(1):148-159. PubMed ID: 38145616
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of osteoporosis with denosumab in patients with decreased kidney function.
    Svendsen OL
    Arch Osteoporos; 2023 Jul; 18(1):104. PubMed ID: 37495795
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bone Histomorphometry in an Osteoporotic Hemodialysis Patient Treated With Denosumab.
    Ibuki Y; Hukuda T; Tabata S; Ito A
    Ther Apher Dial; 2018 Jun; 22(3):302-304. PubMed ID: 28594111
    [No Abstract]   [Full Text] [Related]  

  • 76. Combination Therapy of Denosumab and Calcitriol for a Renal Transplant Recipient with Severe Bone Loss due to Therapy-Resistant Hyperparathyroidism.
    Wada Y; Iyoda M; Iseri K; Arai-Nunota N; Saito T; Hamada T; Tachibana S; Ikeda M; Shibata T
    Tohoku J Exp Med; 2016 Mar; 238(3):205-12. PubMed ID: 26947314
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
    Cummings SR; San Martin J; McClung MR; Siris ES; Eastell R; Reid IR; Delmas P; Zoog HB; Austin M; Wang A; Kutilek S; Adami S; Zanchetta J; Libanati C; Siddhanti S; Christiansen C;
    N Engl J Med; 2009 Aug; 361(8):756-65. PubMed ID: 19671655
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use and safety of denosumab in cancer patients.
    Manzaneque A; Chaguaceda C; Mensa M; Bastida C; Creus-Baró N
    Int J Clin Pharm; 2017 Jun; 39(3):522-526. PubMed ID: 28382583
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New anti-resorptives and antibody mediated anti-resorptive therapy.
    Farrier AJ; Sanchez Franco LC; Shoaib A; Gulati V; Johnson N; Uzoigwe CE; Choudhury MZ
    Bone Joint J; 2016 Feb; 98-B(2):160-5. PubMed ID: 26850419
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk Analysis of Denosumab-Induced Hypocalcemia in Bone Metastasis Treatment: Renal Dysfunction Is Not a Risk Factor for Its Incidence in a Strict Denosumab Administration Management System with Calcium/Vitamin D Supplementation.
    Saito Y; Takekuma Y; Komatsu Y; Sugawara M
    Biol Pharm Bull; 2021; 44(12):1819-1823. PubMed ID: 34853264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.